Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Documents on Hospital-Associated Venous Thromboembolism

Summary of Meeting on Hospital-Associated Venous Thromboembolism

On September 21, 2012,  the Division of Blood Disorders, National Center on Birth Defects and Disabilities, CDC, convened a stakeholder meeting  to assess the need and discuss the development of a public health surveillance plan for hospital associated venous thromboembolism (HA-VTE).   

The objectives of this stakeholder meeting were: 

  • To determine stakeholder interest in and public health need for surveillance of HA-VTE and related prevention activities
  • To identify characteristics  of an ideal surveillance system
  • To determine barriers that might prevent the use of a surveillance system

Learn more about the discussions at this stakeholder meeting.

 

CDC Expert Panel on Hospital-Associated Venous Thromboembolism

Meeting Summary Of Expert Panel
Meeting Summary Cover

View and print this Summary Report»

On August 19, 2011, the Division of Blood Disorders, National Center on Birth Defects and Disabilities, CDC, convened an expert panel of global experts to discuss future research and policy directions for hospital-associated venous thromboembolism (HA-VTE). This topic is one of several key priority areas identified in the “Partnership for Patients” initiative. This initiative is aimed at protecting patients in America’s health care facilities through the prevention of health care-acquired conditions such as venous thromboembolism (VTE).

At this expert panel, invited guests presented and discussed the following topics:

  • Public health importance of VTE prevention
  • VTE prophylaxis among hospitalized patients
  • Design and implementation of effective VTE prevention protocols
  • Hospital systems-level interventions for VTE prevention


Learn more about the discussions held at this expert panel meeting.

Preventing Hospital-Acquired Venous Thromboembolism: A Guide for Effective Quality Improvement

The Agency for Healthcare Research and Quality (AHRQ) calls thromboprophylaxis against VTE the “number one patient safety practice.”1 Proven quality improvement frameworks are needed in hospitals in order to realize improvements in the prevention of HA-VTE. This guide offers a framework to help quality improvement leaders (e.g., hospitalists and others involved in hospital quality improvement programs) achieve key milestones of successful quality improvement initiatives. For more information on the AHRQ guide, see http://www.ahrq.gov/qual/vtguide/.2

  1. Shojania KJ, Duncan BW, McDonald KM, Wachter RM, Markowitz AJ. Making health care safer: A critical analysis of patient safety practices. Evid Rep Technol Assess (Summ). 2001;(43):i-x, 1-668.
  2. Maynard G, Stein J. Preventing Hospital-Acquired Venous Thromboembolism: A Guide for Effective Quality Improvement. Prepared by the Society of Hospital Medicine. AHRQ Publication No. 08-0075. Rockville, MD: Agency for Healthcare Research and Quality. August 2008.

Surgeon General’s Call to Action To Prevent Deep Vein Thrombosis and Pulmonary Embolism

On September 15, 2008, Acting Surgeon General Steven K. Galson released the Surgeon General’s Call to Action To Prevent Deep Vein Thrombosis and Pulmonary Embolism .

 


 

Learn More about Health Insurance Market Place
Contact Us:
  • Centers for Disease Control and Prevention

    National Center on Birth Defects and Developmental Disabilities

    Division of Blood Disorders

    1600 Clifton Road
    MS E-64
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • Contact CDC-INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO